KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Current Assets (2016 - 2025)

Merck (MRK) has disclosed Current Assets for 17 consecutive years, with $43.5 billion as the latest value for Q4 2025.

  • Quarterly Current Assets rose 12.21% to $43.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.5 billion through Dec 2025, up 12.21% year-over-year, with the annual reading at $43.5 billion for FY2025, 12.21% up from the prior year.
  • Current Assets for Q4 2025 was $43.5 billion at Merck, down from $47.6 billion in the prior quarter.
  • The five-year high for Current Assets was $47.6 billion in Q3 2025, with the low at $26.9 billion in Q1 2021.
  • Average Current Assets over 5 years is $34.5 billion, with a median of $32.8 billion recorded in 2023.
  • The sharpest move saw Current Assets dropped 9.95% in 2023, then increased 27.45% in 2024.
  • Over 5 years, Current Assets stood at $30.3 billion in 2021, then rose by 18.03% to $35.7 billion in 2022, then decreased by 9.95% to $32.2 billion in 2023, then grew by 20.56% to $38.8 billion in 2024, then increased by 12.21% to $43.5 billion in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $43.5 billion, $47.6 billion, and $37.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.